A Single-center, Randomized, Double-blind, Placebo-controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Oral Doses of OPC 39436 Spray-dry Tablets in Healthy Elderly Subjects
Phase of Trial: Phase I
Latest Information Update: 09 Aug 2017
At a glance
- Drugs OPC 39436 (Primary)
- Indications Neurological disorders
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Otsuka Pharmaceutical
- 08 Aug 2017 Status changed from active, no longer recruiting to completed.
- 22 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 16 Jun 2016 New trial record